Novel NSCLC Drug Wins FDA Designation
FDA Grants RMAT Designation to HSV-Based Immunotherapy in NSCLC
| Read More |
FDA Grants Orphan Drug Designation to Zenocutuzumab in Cholangiocarcinoma
| Read More |
Videos
|
What to Consider After Diagnosing a Patient With Ductal Carcinoma In Situ
|
 Building Trust and Removing Barriers in Clinical Trial Diversity
|
.png?upscale=true&width=500&upscale=true&name=Video%20Asset%20Deck%20Template%20(Li).png) How to mitigate cardiovascular risks in prostate cancer care?
|
New Career Center Video:
|
Learn how to balance clinical schedules with research, find mentorship, and take next steps in presenting your work with insights from Jonathan W. Lee, MD, MSc, and Chinmay Jani, MD.
|
Trending
 Advancing Precision and Access in Breast Radiation Oncology
|
 RB-1355 Is Safe and Well-Tolerated in B- and T-Cell Lymphomas
|